Construction of quality management system with Chinese characteristic for drug clinical trial institution
Yu-xia XIANG,Zhi-jun HUANG,Chang LIU,Guo-ping YANG
DOI: https://doi.org/10.13699/j.cnki.1001-6821.2017.11.024
2017-01-01
Abstract:Drug clinical trial is the last evaluation stage before marketing,the research materials and data are the principle evidences for the approval of drug.The quality of clinical trial directly affects the quality of medical product and its safety use for public.Inspection storm of clinical trial has exposed that most of sponsors are vacancy in quality management of drug clinical trial,and also exposed that there are many problems in quality control of drug clinical trial institution.Since drug clinical trial institution accreditation in 2004,it paid more attention in clinical quality,the strength of quality control increased constantly,and the quality of clinical trial were also improved with a certain extent,but it still has a large gap to the core of good clinical practice (GCP).In the author's opinion,the quality of clinical trial can not only rely on the pure quality control.According to the current management situation of Chinese hospital,we should establish quality management systems form of hospital and clinical specialties.The quality management system is a cycle system which was incorporated with organization and its functions,management documents,training,quality control,system evaluation and continuous improvement,only when it run well,can the clinical trials be ensured to be scientific and ethical,and the data to be true,complete,accurate and reliable.